4Kerk N, Goerge T. Livedoid vasculopathy-current aspects of diagnosis and treatment of cutaneous infarction[J]. J Dtsch Dermatol Ges, 2013, 11: 407-410.
5Gibbs MB, English JC, Zirwas MJ. Livedo reticularis:an update [J]. J Am Acad Dermatol, 2005, 52(6): 1009-1019.
6Voilum DI, Parkes JD, Doyle D. Livedo reticularis during aman- tadine treatment[J]. Br Med J, 1971, 2(5762): 627-628.
7Hayes BB, Cook-Norris RH, Miller JL, et al. Amantadine-in- duced livedo reticularis: a report of two cases[J]. J Drugs Der- matol, 2006, 5(3): 288-289.
8Rana AQ, Masroor MS. Patient perception of levido reticularis due to amantadine[J]. Int J Neurosci, 2012, 122(7): 363-366.
9Singer C, Papapetropoulos S, Gonzalez MA, et al. Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series[J]. Mov Disord, 2005, 20(7): 873-877.
10Shealy C, Weeth JB, Mercier D. Livedo reticularis in patients with parkinsonism receiving amantadine[J]. JAMA, 1970, 212(9): 1522-1523.
